Rigel Pharmaceuticals (RIGL) Times Interest Earned (2010 - 2026)
Rigel Pharmaceuticals (RIGL) recorded quarterly Times Interest Earned of $8.29 in Q1 2026, down 39.18% quarter-over-quarter from $13.64 in Q4 2025, and up 20.32% on a YoY basis from $6.89 in Q1 2025.
Rigel Pharmaceuticals (RIGL) Times Interest Earned (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Times Interest Earned history runs 10 years deep, the most recent figure standing at $8.29 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 20.32% year-over-year to $8.29; the TTM figure through Mar 2026 stood at $18.05 (up 224.55% YoY), while the FY2025 annual figure was $17.14, up 460.99% from the prior year.
- Times Interest Earned was $8.29 for Q1 2026 at Rigel Pharmaceuticals, down from $13.64 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $32.61 in Q2 2025 to a low of -$22.79 in Q2 2022.
- Historically, Times Interest Earned has averaged $0.5 across 5 years, with a median of $1.03 in 2023.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned tumbled 207.17% in 2022, then surged 14700.2% in 2025.
- A 5-year view of Times Interest Earned shows it stood at $1.88 in 2022, then slumped by 45.11% to $1.03 in 2023, then jumped by 726.35% to $8.52 in 2024, then jumped by 60.08% to $13.64 in 2025, then sank by 39.18% to $8.29 in 2026.
- The last three Times Interest Earned figures came in at $8.29 (Q1 2026), $13.64 (Q4 2025), and $15.01 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | 8.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.29 |
| Dec 31, 2025 | 13.64 |
| Sep 30, 2025 | 15.01 |
| Jun 30, 2025 | 32.61 |
| Mar 31, 2025 | 6.89 |
| Dec 31, 2024 | 8.52 |
| Sep 30, 2024 | 6.82 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | -3.72 |
| Dec 31, 2023 | 1.03 |
| Sep 30, 2023 | -2.35 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | -10.57 |
| Dec 31, 2022 | 1.88 |
| Sep 30, 2022 | -22.28 |
| Jun 30, 2022 | -22.79 |
| Mar 31, 2022 | -21.79 |
| Dec 31, 2021 | -16.49 |
| Sep 30, 2021 | -15.02 |
| Jun 30, 2021 | -7.42 |